Viewing Study NCT05776134


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-26 @ 1:15 AM
Study NCT ID: NCT05776134
Status: AVAILABLE
Last Update Posted: 2025-01-10
First Post: 2023-03-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Sponsor: Kite, A Gilead Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module